SEATTLE, September 4, 2025 – Proprio, the global leader in AI-powered surgical technology, is pleased to announce the addition of Adam Spice to its Board of Directors. Spice, currently the Chief Financial Officer at Rocket Lab, an aerospace company that is a global leader in launch services and space systems, brings deep financial expertise and a proven track record of guiding high-growth, deep technology companies through operational scaling and global commercialization.
“From our first conversation, it was obvious Adam was the caliber of leader who understands and excels at revolutionizing rigid, high-barrier industries that require deep technical acumen,” said Gabriel Jones, CEO of Proprio. “His strategic depth and relentless drive match the scale of our vision — to reinvent surgery and set a new standard for what’s possible in the operating room.”
Spice’s experience in the high-stakes world of hypergrowth in the aerospace industry, coupled with his expertise in scaling complex organizations, will be invaluable as Proprio continues to expand its AI-powered surgical technology platform globally. At Rocket Lab, Spice has been instrumental in driving the company's impressive growth trajectory, achieving 78% year-over-year revenue growth. The timing of Spice's appointment comes as Proprio experiences significant momentum following its FDA clearances for the world's first AI surgical guidance platform.
“I am thrilled to join Proprio at this critical stage in its journey,” said Adam Spice. “The company’s focus on improving surgical outcomes and delivering real-time insights through AI aligns perfectly with my belief in the power of breakthrough technology to reshape entire industries. I’m excited to collaborate with Gabe and the team to drive meaningful change in healthcare.”
Proprio and Rocket Lab share a common ethos of pushing the boundaries of their respective industries and creating entirely new categories of technology. Rocket Lab, with its industry-leading rockets and spacecraft, and Proprio, with its revolutionary approach to AI-powered surgical guidance, are reshaping what’s possible. Both companies focus on cost-effective innovation and efficient utilization of existing technologies to unlock new capabilities that were previously impossible.
"Great investors back founders who don’t just solve today’s problems—they define what comes next,” said Alan Cohen, board member at Proprio and General Partner at DCVC, which has invested in both Proprio and Rocket Lab. “At DCVC, we back entrepreneurs who fuse rigorous science with cutting-edge computation to tackle trillion-dollar, change-resistant industries. Rocket Lab and Proprio both embody this approach—one making space accessible, the other transforming surgery with AI. Adam’s track record scaling complex technologies and driving operational excellence makes him an ideal addition to the board to guide Proprio’s global growth.”
Adam Spice joins a distinguished board that includes other industry leaders who support Proprio's mission of dramatically improving healthcare outcomes through AI-powered surgical technology. His appointment strengthens Proprio's financial leadership as the company continues to expand its platform into multiple data applications, surgical specialties, and international markets.
About Proprio
Proprio is the global leader in AI-powered surgical technology. The company's flagship product, the Proprio Paradigm platform, revolutionizes the surgical process by providing AI-guided visualization and data-driven insights that improve precision, efficiency, and patient outcomes. Over 200 of the world's leading neuro and orthopedic surgeons have contributed to building Proprio. For more information, visit proprio.ai.
.svg)
.svg)
